Healthcare Triangle Terminates Material Agreement

TL;DR

**HCTI just terminated a key agreement, watch for impact on future business.**

AI Summary

Healthcare Triangle, Inc. (HCTI) announced on January 30, 2024, the termination of a material definitive agreement. This termination could signal a shift in the company's strategic direction or operations, potentially impacting future revenue streams or partnerships. Investors should monitor for further details on why the agreement was terminated and its financial implications, as it could affect the company's growth prospects and stock performance.

Why It Matters

The termination of a material agreement can significantly alter a company's business outlook, potentially affecting its financial health and future growth opportunities.

Risk Assessment

Risk Level: medium — The termination of a material agreement introduces uncertainty regarding the company's future operations and financial performance, warranting a medium risk assessment.

Analyst Insight

Investors should seek further information from Healthcare Triangle, Inc. regarding the specifics of the terminated agreement and its potential financial and operational impact before making investment decisions.

Key Players & Entities

• Healthcare Triangle, Inc. (company) — the registrant filing the 8-K
• January 30, 2024 (date) — date of the earliest event reported
• HCTI (company) — trading symbol for Healthcare Triangle, Inc.
• The Nasdaq Stock Market LLC (company) — exchange where HCTI's common stock is registered

Forward-Looking Statements

• Healthcare Triangle, Inc. will provide more details on the terminated agreement's impact in its next quarterly earnings report. (Healthcare Triangle, Inc.) — medium confidence, target: Q1 2024 Earnings Report

FAQ

Key Financial Figures

• $0.00001 — ch registered Common Stock, par value $0.00001 per share HCTI The Nasdaq Stock Mar

Filing Documents

• ea192762-8k_health.htm (8-K) — 26KB
• ea192762ex99-1_health.htm (EX-99.1) — 7KB
• ex99-1_001.jpg (GRAPHIC) — 5KB
• ex99-1_002.jpg (GRAPHIC) — 6KB
• 0001213900-24-009734.txt ( ) — 220KB
• hcti-20240130.xsd (EX-101.SCH) — 3KB
• hcti-20240130_lab.xml (EX-101.LAB) — 33KB
• hcti-20240130_pre.xml (EX-101.PRE) — 22KB
• ea192762-8k_health_htm.xml (XML) — 4KB

02 Termination of a Material Definitive Agreement

Item 1.02 Termination of a Material Definitive Agreement. On January 30, 2024, Devcool, Inc. (the "Supplier"), a wholly-owned subsidiary of the Healthcare Triangle, Inc. ("HCTI" or the "Company") received a letter from Guidant Global Inc. ("Guidant"), terminating the Supplier Master Services Agreement (the "Agreement") by and between Guidant and the Supplier, regarding the Supplier's services to City of Hope National Medical Center, City of Hope Medical Foundations, Beckman Research Institute of the City of Hope, and City of Hope effective February 04, 2024. The Company is currently assessing the materiality of the termination of the Agreement and the impact of the potential termination. A copy of the termination letter is filed with this report as Exhibit 99.1 and is incorporated herein by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Termination Letter, dated as of January 30, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Healthcare Triangle, Inc. Date: February 2, 2024 By: /s/ Thyagarajan Ramachandran Name: Thyagarajan Ramachandran Title: Chief Financial Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR